Welcome to Sun-shine chemical
+86-27-65522453 sales@sun-shinechem.com
611902 | PF-04979064

6119021220699-06-8

PF-04979064

details
171680 | Bexotegrast  ( PLN-74809 )

1716802376257-44-0

Bexotegrast ( PLN-74809 )

details
20318 | Zotizalkib ( TPX-0131 )

203182648641-36-3

Zotizalkib ( TPX-0131 )

details
20369 | Sunvozertinib ( DZD 9008 )

203692370013-12-8

Sunvozertinib ( DZD 9008 )

details
1711225 | Fosgonimeton (ATH-1017)

17112252093305-05-4

Fosgonimeton (ATH-1017)

details
171462 | MRTX0902

1714622654743-22-1

MRTX0902

details
822221 | IACS-13909

8222212160546-07-4

IACS-13909

details
232251 | Brepocitinib ( PF-06700841 )

2322511883299-62-4

Brepocitinib ( PF-06700841 )

details

WE SPECIALIZE IN PROVIDING ADVANCED ORGANIC CHEMICALS
TO HELP OUR CLIENTS ON SCIENTIFIC RESEARCH

RECOMMENDED PRODUCTSMORE >>


Catalog NoChemical NameCAS NumberPurity
611902 PF-04979064
PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with an IC(50)
1220699-06-8 ≧98.0%
171680 Bexotegrast ( PLN-74809 )
Bexotegrast (Synonyms: PLN-74809) is a small-molecule, dual selective inhibitor of α
2376257-44-0 ≧98.0%
18435 Ritlecitinib ( PF-06651600 )
Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a
1792180-81-4 ≧98.0%
20318 Zotizalkib ( TPX-0131 )
TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated
2648641-36-3 ≧98.0%
20369 Sunvozertinib ( DZD 9008 )
Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective
2370013-12-8 ≧98.0%
1711225 Fosgonimeton (ATH-1017)
Fosgonimeton (ATH-1017) is a small molecule which enhance the activity of hepatocyte
2093305-05-4 ≧98.0%
171462 MRTX0902
MRTX0902is a potent SOS1 inhibitor which can be used for the therapeutic intervention
2654743-22-1 ≧98.0%
61726 Ensifentrine ( RPL554 )
Ensifentrine (RPL554) is an investigational, first-in-class, inhaled dual inhibitor o
1884461-72-6 ≧98.0%
822221 IACS-13909
IACS-13909 is a specific and potent allosteric inhibitor of SHP2, that suppresses sig
2160546-07-4 ≧98.0%
232251 Brepocitinib ( PF-06700841 )
Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1
1883299-62-4 ≧98.0%
20258 CRT0273750
CRT0273750 modulates LPA levels in plasma and is suitable for in vivo studies.
1979939-16-6 ≧98.0%
20376 TOFA ( RMI14514; MDL14514)
TOFA ( RMI14514; MDL14514) is an allosteric inhibitor of acetyl-CoA carboxylase-α (A
54857-86-2 ≧98.0%
20102901 Razuprotafib
Razuprotafib, also known as AKB-9778, is a small molecule inhibitor of vascular endot
1008510-37-9 ≧98.0%
2105071 AP1189 acetate
AP1189 is a melanocortin receptor agonist on MC1 and MC3 receptors.
959850-74-9 ≧98.0%
20103003 ML380
ML380 is a highly potent and the first CNS penetrant M5 positive allosteric modulator
1627138-52-6 ≧98.0%